Zobrazeno 1 - 10
of 212
pro vyhledávání: '"Berk, V"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Muhammet Ali Kaplan, Oruc Z, Gumus M, Ozaydın S, Et, Elkiran, Ns, Dinc, Sakin A, Berk V, Akman T, Aytekin A, Yazilitas D, Dane F, Gi, Imamoglu, Cubukcu E, Isikdogan A
Publikováno v:
Europe PubMed Central
Purpose: To analyze the reliability and the effectiveness of chemotherapy and prognostic factors for survival in patients with HER2 (human epidermal growth receptor 2) negative early-stage breast cancer treated with adjuvant sequential anthracycline-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0d671373aae8714129d91ae9252df918
https://avesis.yyu.edu.tr/publication/details/85e0cee8-9b78-4c32-8b23-fee45f2b2d46/oai
https://avesis.yyu.edu.tr/publication/details/85e0cee8-9b78-4c32-8b23-fee45f2b2d46/oai
Autor:
Aydin, D., Mehmet Sendur, Kefeli, U., Unal, O. U., Tastekin, D., Akyol, M., Tanrikulu, E., Ciltas, A., Ustaalioglu, B. B., Dede, D. S., Esbag, O., Inal, A., Bilir, C., Bilici, A., Harputlu, H., Berk, V., Sevinc, A., Ozdemir, N. Y., Yildirim, E., Sonkaya, A., Ustaoglu, M. A., Gumus, M.
Publikováno v:
Scopus-Elsevier
WOS: 000388782200027 PubMed ID: 27837629 Purpose: Small bowel adenocarcinoma (SBA) is a rare tumor of the gastrointestinal system with poor prognosis. Since these are rarely encountered tumors, there are limited numbers of studies investigating syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::39b17920c4db6c3cf8c23c648f50ceb5
https://avesis.deu.edu.tr/publication/details/a379a062-ccdc-40da-9797-8e896c356186/oai
https://avesis.deu.edu.tr/publication/details/a379a062-ccdc-40da-9797-8e896c356186/oai
Autor:
Uncu, D., Kaplan, M. A., Odabasi, H., Ozdemir, N., Harputluoglu, H., Aliustaoglu, M., Berk, V., Gunaydin, Y., Elkiran, T., Aydin, D., Isikdogan, A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10046::a962e9fac95e6e8d8cc1fd09e0f76d71
https://avesis.gazi.edu.tr/publication/details/974f3bee-bc94-4628-a45c-b64b6f6fc208/oai
https://avesis.gazi.edu.tr/publication/details/974f3bee-bc94-4628-a45c-b64b6f6fc208/oai
Autor:
HELVACı, K, OZTOP, İ, TURAN, Nuriye Burçin, ALGıN, E, ULGER, S, DOGAN, E, BERK, V, BALAKAN, O, EKINCI, AŞ, UYSAL, M, PETEKKAYA, İ, TONYALı, Ö, DANE, F, ÇETIN, B, Aldemir, Mehmet Naci, UNER, A, OZDEMIR, N, COSKUN, U, OZET, A, BUYUKBERBER, S, Anatolian, Society, TUFAN, G, TURKMEN, E, URAKCI, Z, BENEKLI, M, UNAL, OU, EREN, T, OZTURK, SC, BABACAN, NA, UNEK, İT, TOPCU, TO, TASTEKIN, D, USTAALIOGLU, BO, UYSAL, OS, ERCELEP, OB, TASKOYLU, BY, AKSOY, A, CANHOROZ, M, DEMIRCI, U
Background: We examined the impact of adjuvant modalities on resected pancreatic and periampullary adenocarcinoma (PAC). Methods: A total of 563 patients who were curatively resected for PAC were retrospectively analyzed between 2003 and 2013. Result
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::00f4c031629afc389c061e99e48ee2fc
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/10531
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/10531
Autor:
Turan, N, Benekli, M, Unal, OU, Unek, IT, Tastekin, D, Dane, F, Algin, E, Ulger, S, Eren, T, Topcu, TO, Turkmen, E, Babacan, NA, Tufan, G, Urakci, Z, Ustaalioglu, BO, Uysal, OS, Ercelep, OB, Taskoylu, BY, Aksoy, A, Canhoroz, M, Demirci, U, Dogan, E, Berk, V, Balakan, O, Ekinci, AS, Uysal, M, Petekkaya, I, Ozturk, SC, Tonyali, O, Cetin, B, Aldemir, MN, Helvaci, K, Ozdemir, N, Oztop, I, Coskun, U, Uner, A, Ozet, A, Buyukberber, S
Background: We examined the impact of adjuvant modalities on resected pancreatic and periampullary adenocarcinoma (PAC). Methods: A total of 563 patients who were curatively resected for PAC were retrospectively analyzed between 2003 and 2013. Result
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7918cdd6a5afaa52083836cca427e464
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/22373
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/22373
Autor:
Gumusay, O, Coskun, U, Akman, T, Ekinci, AS, Kocar, M, Erceleb, OB, Yazici, O, Kaplan, MA, Berk, V, Cetin, B, Taskoylu, BY, Yildiz, A, Goksel, G, Alacacioglu, A, Demirci, U, Algin, E, Uysal, M, Oztop, I, Oksuzoglu, B, Dane, F, Gumus, M, Buyukberber, S
The development of brain metastases (BMs) was associated with poor prognosis in melanoma patients. Patients with BMs have a median survival of < 6 months. Melanoma is the third most common tumor to metastasize to the brain with a reported incidence o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cb10842f5869e27f3451fa272b4b1993
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/14605
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/14605
Purpose: Triple-negative breast cancers account for 15% of breast carcinomas and, when present as early-stage disease, they are associated with higher rates of recurrence and early distant metastasis risk when compared to hormone receptor positive an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10652::924f6de11aaaf990a61acc54fc2dcde8
https://hdl.handle.net/11499/7364
https://hdl.handle.net/11499/7364